The virology of cervical neoplasia: An HPV-associated malignancy

Cancer Journal

Volumn 9, Issue 5, 2003, Pages 360-367

  Stoler, Mark H ^a,b  

^a University of Virginia Health System ^*

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Cancer; Cervix; HPV; Papillomavirus; Pathogenesis; Screening

Indexed keywords

BIOLOGICAL MODEL; CANCER CLASSIFICATION; CARCINOGENESIS; DIAGNOSTIC PROCEDURE; EPITHELIUM; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; UTERINE CERVIX CANCER; VIROLOGY; WART VIRUS; FEMALE; PAPILLOMA VIRUS; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR;

CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; PAPILLOMAVIRIDAE; UTERINE CERVICAL NEOPLASMS;

EID: 1542439974     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/00130404-200309000-00005     Document Type: Review

References (110)

1. Ciuffo G. Imnfesto positive con filtrate di verruca volgare. Giorn Ital Mal Venereol 1907;48:12-17.
2. Shope RE, Hurst EW. Infectious papillomatosis of rabbits: with a note on the histopathology. J Exp Med 1933;58:607-624.
3. Rous P, Kidd JG. The carcinogenic effect of a virus on tarred skin. Science 1936;83:468-469.
4. Kidd JG, Rous P. A transplantable rabbit carcinoma originating in a virus induced papilloma and containing the virus in masked or altered form. J Exp Med 1940;71:813-837.
5. Blank H, Davis C, Collins C. Electron microscopy for the diagnosis of cutaneous viral infections. Br J Dermatol 1970;83[suppl]: 69-80.
6. Boyle WF, Riggs JL, Oshiro LS, Lennette EH. Electron microscopic identification of papova virus in laryngeal papilloma. Laryngoscope 1973;83:1102-1108.
7. Hills E, Laverty CR. Electron microscopic detection of papilloma virus particles in selected koilocytotic cells in a routine cervical smear. Acta Cytol 1979;23:53-56.
8. Smith J, Coleman DV. Electron microscopy of cells showing viral cytopathic effects in Papanicolaou smears. Acta Cytol 1983;27: 605-613.
9. Rowson KEK, Mahy BWJ. Human papova (wart) virus infection. Bacteriol Rev 1967;31:110-131.
10. Gissmann L, Pfister H, H. z. Human papilloma viruses (HPV): characterization of four different isolates. Virology 1977;76: 569-580.
11. Gissmann L, deVilliers EM, zur Hausen H. Analysis of human genital warts (condylomata acuminata) and other genital tumors for human papillomavirus type 6 DNA. Int J Cancer 1982;29: 143-146.
12. de Villiers EM. Human pathogenic papillomavirus types: an update. Curr Top Microbiol Immunol 1994;186:1-12.
13. de Villiers EM. Papillomavirus and HPV typing. Clin Dermatol 1997;15:199-206.
14. Koutsky LA, Galloway DA, Holmes KK. Epidemiology of genital human papillomavirus infection. Epidemiol Rev 1988;10: 122-163.
15. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997;102:3-8.
16. Howley PM. Chapter 65: Papillomaviruses and their Replication. In: Field BN, Knipe DM, eds. Fields Virology, vol 2, 3rd ed. New York: Raven Press; 1995:947-979.
17. Van Ranst M, Kaplan JB, Burk RD. Phylogenetic classification of human papillomaviruses: correlation with clinical manifestations. J Gen Virol 1992;73[pt 10]:2653-2660.
18. Van Ranst MA, Tachezy R, Delius H et al. Taxonomy of the human papillomaviruses. Papillomavirus Rep 1993;3:61-65.
19. Ho GY, Burk RD, Fleming I et al. Risk of genital human papillomavirus infection in women with human immunodeficiency virus-induced immunosuppression. Int J Cancer 1994;56: 788-792.
20. Bernard HU. Coevolution of papillomaviruses with human populations. Trends Microbiol 1994;2:140-143.
21. Lorincz AT, Reid R, Jenson AB et al. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 1992;79:328-337.
22. Munoz N, Bosch FX. The causal link between HPV and cervical cancer and its implications for prevention of cervical cancer. Bull Pan Am Health Org 1996;30:362-377.
23. Munoz N, Bosch FX, de Sanjose S et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-527.
24. Wilbur DC, Reichman RC, Stoler MH. Detection of infection by human papillomavirus in genital condylomata: a comparison study using immunocytochemistry and in situ nucleic acid hybridization. Am J Clin Pathol 1988;89:505-510.
25. Munoz N, Bosch FX, Shah KV et al, eds. The Epidemiology of Human Papillomavirus and Cervical Cancer. New York: Oxford University Press; 1992. IARC Scientific Publication No. 119.
26. Schiffman MH, Bauer HM, Hoover RN et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia [see comments]. J Nat Cancer Inst 1993;85:958-964.
27. Schiffman MH. Epidemiology of cervical human papillomavirus infections. Curr Top Microbiol Immunol 1994;186:55-81.
28. Schiffman MH, Brinton LA. The epidemiology of cervical carcinogenesis. Cancer 1995;76[10 suppl]:1888-1901.
29. Munoz N, Franceschi S, Bosetti C et al. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet 2002;359:1093-1101.
30. Stoler MH. Advances in cervical screening technology. Mod Pathol 2000;13:275-284.
31. Koss LG, Durfee GR. Unusual patterns of squamous epithelium of the uterine cervix: cytologic and pathologic study of koilocytotic atypia. Ann NY Acad Sci 1956;63:1245-1261.
32. Meisels A, Fortin R. Condylomatous lesions of the cervix and vagina. I: cytologic patterns. Acta Cytol 1976;20:505-509.
33. Meisels A. The story of a cell. The George N. Papanicolaou Award lecture. Acta Cytol 1983;27:584-596.
34. Purola E, Savia E. Cytology of gynecologic condyloma acuminatum. Acta Cytol 1977;21:26-31.
35. Kurman RJ, Shah KH, Lancaster WD et al. Immunoperoxidase localization of papillomavirus antigens in cervical dysplasia and vulvar condylomas. Am J Obstet Gynecol 1981;140:931-935.
36. Kurman RJ, Sanz LE, Jenson AB et al. Papillomavirus infection of the cervix. 1: Correlation of histology with viral structural antigens and DNA sequences. Int J Gynecol Pathol 1982;1:17-28.
37. Kurman RJ, Jenson AB, Lancaster WD. Papillomavirus infection of the cervix. II: relationship to intraepithelial neoplasia based on the presence of specific viral structural proteins. Am J Surg Pathol 1983;7:39-52.
38. Laverty C. Noncondylomatous wart virus infection of the cervix: cytologic, histologic and electronmicroscopic features. Obstet Gynecol Surv 1979;34:820-822.
39. Sato S, Okagaki T, Clark BA et al. Sensitivity of koilocytosis, immunocytochemistry, and electron microscopy as compared to DNA hybridization in detecting human papillomavirus in cervical and vaginal condyloma and intraepithelial neoplasia. Int J Gynecol Pathol 1986;5:297-307.
40. Toki T, Oikawa N, Tase T et al. Immunohistochemical and electron microscopic demonstration of human papillomavirus in dysplasia of the uterine cervix. Tohoku J Exp Med 1986;149: 163-167.
41. Bergeron C, Barrasso R, Beaudenon S et al. Human papillomaviruses associated with cervical intraepithelial neoplasia: great diversity and distinct distribution in low-grade and high-grade lesions. Am Surg Pathol 1992;16:641-649.
42. Kurman RJ, Norris HJ, Wilkinson EJ. Tumors of the Cervix, Vagina and Vulva, vol 4, 3rd ed. Washington, DC: Armed Forces Institute of Pathology, 1990.
43. Duggan MA, Benoit JL, McGregor SE et al. The human papillomavirus status of 114 endocervical adenocarcinoma cases by dot blot hybridization [see comments]. Hum Pathol 1993;24: 121-125.
44. Farnsworth A, Laverty C, Stoler MH. Human papillomavirus messenger RNA expression in adenocarcinoma in situ of the uterine cervix. Int J Gynecol Pathol 1989;8:321-330.
45. Tase T, Sato S, Wada Y et al. Prevalence of human papillomavirus type 18 DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix occurring in Japan. Tohoku J Exp Med 1988; 156:47-53.
46. Stoler MH, Mills SE, Gersell DJ et al. Small-cell neuroendocrine carcinoma of the cervix: a human papillomavirus type 18-associated cancer. Am J Surg Pathol 1991;15:28-32.
47. Campion MJ, McCance DJ, Cuzick J et al. Progressive potential of mild cervical atypia: prospective cytological, colposcopic, and virological study. Lancet 1986;2:237-240.
48. Kiviat NB, Koutsky LA, Critchlow CW et al. Prevalence and cytologic manifestations of human papilloma virus (HPV) types 6, 11, 16, 18, 31, 33, 35, 42, 43, 44, 45, 51, 52, and 56 among 500 consecutive women. Int J Gynecol Pathol 1992;11:197-203.
49. Clifford GM, Smith JS, Plummer M et al. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003;88:63-73.
50. Lutzner MA. Papillomavirus lesions in immunodepression and immunosuppression. Clin Dermatol 1985;3:165-169.
51. Schneider A, de Villiers EM, Schneider V. Multifocal squamous neoplasia of the female genital tract: significance of human papillomavirus infection of the vagina after hysterectomy. Obstet Gynecol 1987;70:294-298.
52. zur Hausen H. Human papillomaviruses and their possible role in squamous cell carcinomas. Curr Topics Microbiol Immunol 1977;78:1-30.
53. zur Hausen H. Papillomaviruses in human cancer. Cancer 1987; 59:1692-1696.
54. Stoler MH, Rhodes CR, Whitbeck A, Wolinsky SM, Chow LT, Broker TR. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum Pathol 1992;23(2):117-128.
55. Crum CP, Barber S, Symbula M et al. Coexpression of the human papillomavirus type 16 E4 and L1 open reading frames in early cervical neoplasia. Virology 1990;178:238-246.
56. Stoler MH, Broker TR. In situ hybridization detection of human papillomavirus DNAs and messenger RNAs in genital condylomas and a cervical carcinoma. Hum Pathol 1986;17:1250-1258.
57. Stoler MH, Wolinsky SM, Whitbeck A et al. Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridization with message-specific RNA probes. Virology 1989;172:331-340.
58. Stoler MH, Whitbeck A, Wolinsky SM et al. Infectious cycle of human papillomavirus type 11 in human foreskin xenografts in nude mice. J Virol 1990;64:3310-3318.
59. Smotkin D, Wettstein FO. Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc Natl Acad Sci USA 1986;83:4680-4684.
60. Baker CC, Phelps WC, Lindgren V et al. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol 1987;61:962-971.
61. Boshart M, Gissmann L, Ikenberg H et al. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J 1984;3:1151-1157.
62. Schwarz E, Freese UK, Gissmann L et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985;314:111-114.
63. Yee C, Krishnan HI, Baker CC et al. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol 1985;119:361-366.
64. Schneider-Gadicke A, Schwarz E. Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO J 1986;5:2285-2292.
65. Land H, Parada LF, Weinberg RA. Cellular oncogenes and multistep carcinogenesis. Science 1983;222:771-778.
66. Matlashewski G, Schneider J, Banks L et al. Human papillomavirus type 16 DNA cooperates with activated ras in transforming primary cells. EMBO J 1987;6:1741-1746.
67. Matlashewski G, Osborn K, Banks L et al. Transformation of primary human fibroblast cells with human papillomavirus type 16 DNA and EJ-ras. Int J Cancer 1988;42:232-238.
68. Storey A, Pim D, Murray A et al. Comparison of the in vitro transforming activities of human papillomavirus types. EMBO J 1988;7:1815-1820.
69. Storey A, Banks L. Human papillomavirus type 16 E6 gene cooperates with EJ-ras to immortalize primary mouse cells. Oncogene 1993;8:919-924.
70. Pirisi L, Yasumoto S, Feller M et al. Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J Virol 1987;61:1061-1066.
71. Pirisi L, Batova A, Jenkins GR et al. Increased sensitivity of human keratinocytes immortalized by human papillomavirus type 16 DNA to growth control by retinoids. Cancer Res 1992;52: 187-193.
72. Woodworth CD, Doniger J, DiPaolo JA. Immortalization of human foreskin keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical carcinoma. Journal of Virology 1989;63:159-164.
73. Woodworth CD, Waggoner S, Barnes W et al. Human cervical and foreskin epithelial cells immortalized by human papillomavirus DNAs exhibit dysplastic differentiation in vivo. Cancer Res 1990; 50:3709-3715.
74. McCance DJ, Kopan R, Fuchs E et al. Human papillomavirus type 16 alters human epithelial cell differentiation in vitro. Proc Natl Acad Sci USA 1988;85:7169-7173.
75. Laimins LA. The biology of human papillomaviruses: from warts to cancer. Infect Agents Dis 1993;2:74-86.
76. El-Awady MK, Kaplan JB, O'Brien SJ et al. Molecular analysis of integrated human papillomavirus 16 sequences in the cervical cancer cell line SiHa. Virology 1987;159:389-398.
77. Choo KB, Pan CC, Liu MS et al. Presence of episomal and integrated human papillomavirus DNA sequences in cervical carcinoma. J Med Virol 1987;21:101-107.
78. Choo KB, Pan CC, Han SH. Integration of human papillomavirus type 16 into cellular DNA of cervical carcinoma: preferential deletion of the E2 gene and invariable retention of the long control region and the E6/E7 open reading frames. Virology 1987; 161:259-261.
79. Matsukura T, Koi S, Sugase M. Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers. Virology 1989;172:63-72.
80. Shirasawa H, Tomita Y, Kubota K et al. Detection of human papillomavirus type 16 DNA and evidence for integration into the cell DNA in cervical dysplasia. J Gen Virol 1986;67:2011-2015.
81. Shirasawa H, Tomita Y, Sekiya S et al. Integration and transcription of human papillomavirus type 16 and 18 sequences in cell lines derived from cervical carcinomas. J Gen Virol 1987;68: 583-591.
82. Cullen AP, Reid R, Campion M, Lorincz AT. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol 1991;65: 606-612.
83. Chin MT, Hirochika R, Hirochika H et al. Regulation of human papillomavirus type 11 enhancer and E6 promoter by activating and repressing proteins from the E2 open reading frame: functional and biochemical studies. J Virol 1988;62:2994-3002.
84. Munger K, Phelps WC, Bubb V et al. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 1989;63:4417-4421.
85. Phelps WC, Yee CL, Munger K et al. Functional and sequence similarities between HPV16 E7 and adenovirus E1A. Curr Topics Microbiol Immunol 1989;144:153-166.
86. Dyson N, Howley PM, Munger K et al. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989;243:934-937.
87. Munger K, Werness BA, Dyson N et al. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J 1989;8:4099-4105.
88. Howley PM, Munger K, Werness BA et al. Molecular mechanisms of transformation by the human papillomaviruses. Int Symp Princess Takamatsu Cancer Res Fund 1989;20:199-206.
89. Phelps WC, Yee CL, Munger K et al. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell 1988;53:539-547.
90. Scheffner M, Werness BA, Huibregtse JM et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990;63:1129-1136.
91. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990; 248:76-79.
92. Werness BA, Munger K, Howley PM. Role of the human papillomavirus oncoproteins in transformation and carcinogenic progression. Imp Adv Oncol 1991;1991:3-18.
93. Huibregtse JM, Scheffner M, Howley PM. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J 1991;10:4129-4135.
94. Scheffner M, Munger K, Byrne JC et al. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci USA 1991;88:5523-5527.
95. Munger K, Scheffner M, Huibregtse JM et al. Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products. Cancer Surv 1992;12:197-217.
96. Scheffner M, Takahashi T, Huibregtse JM et al. Interaction of the human papillomavirus type-16 E6 oncoprotein with wild-type and mutant human p53 proteins. J Virol 1992;66:5100-5105.
97. Crook T, Wrede D, Vousden KH. p53 point mutation in HPV negative human cervical carcinoma cell lines. Oncogene 1991; 6:873-875.
98. Crook T, Wrede D, Tidy JA et al. Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours [see comments]. Lancet 1992;339:1070-1073.
99. Fujita M, Inoue M, Tanizawa O et al. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Cancer Res 1992;52:5323-5328.
100. Kessis TD, Slebos RJ, Han SM et al. p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix. Am J Pathol 1993;143:1398-1405.
101. Lechner MS, Laimins LA. Inhibition of p53 DNA binding by human papillomavirus E6 proteins. J Virol 1994;68:4262-4273.
102. Stoler MH. Human papillomaviruses and cervical neoplasia: a model for carcinogenesis. Int J Gynecol Pathol 2000;19:16-28.
103. Stoler MH. The biology of papillomaviruses. Pathol Case Rev 1997;2:1-13.
104. Dollard SC, Wilson JL, Demeter LM et al. Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures. Gene Dev 1992;6:1131-1142.
105. Demeter LM, Stoler MH, Sobel ME et al. Expression of high-affinity laminin receptor mRNA correlates with cell proliferation rather than invasion in human papillomavirus-associated cervical neoplasms. Cancer Res 1992;52:1561-1567.
106. Demeter LM, Stoler MH, Broker TR et al. Induction of proliferating cell nuclear antigen in differentiated keratinocytes of human papillomavirus-infected lesions. Hum Pathol 1994;25:343-348.
107. Scully RE, Bonfiglio TA, Kurman RJ et al. Histological Typing of Female Genital Tract Tumours, 2nd ed. Berlin: Springer-Verlag, 1994.
108. Solomon D, Davey D, Kurman R et al. The 2001 Bethesda System: t erminology for reporting results of cervical cytology. JAMA 2002; 287:2114-2119.
109. Stoler MH. New Bethesda terminology and evidence-based management guidelines for cervical cytology findings. JAMA 2002; 287:2140-2141.
110. Wright TC Jr, Cox JT, Massad LS et al. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-2129.